Presymptomatic and symptomatic ALS SOD1(G93A) mice differ in adenosine A1 and A2A receptor-mediated tonic modulation of neuromuscular transmission

Purinergic Signalling

Volumn 11, Issue 4, 2015, Pages 471-480

  Nascimento, Filipe ^a,b   Sebastião, Ana M ^a   Ribeiro, Joaquim A ^a  

^a UNIVERSITY OF LISBON   (Portugal)

^b UNIVERSITY OF ST ANDREWS   (United Kingdom)

Author keywords

Adenosine; ALS; Neuromuscular transmission; SOD1(G93A) mice

Indexed keywords

6 N CYCLOPENTYLADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE DEAMINASE; 1,3-DIPROPYL-8-CYCLOPENTYLXANTHINE; 2-(4-(2-CARBOXYETHYL)PHENETHYLAMINO)-5'-N-ETHYLCARBOXAMIDOADENOSINE; ADENOSINE; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A2 RECEPTOR AGONIST; COPPER ZINC SUPEROXIDE DISMUTASE; N(6)-CYCLOPENTYLADENOSINE; PHENETHYLAMINE DERIVATIVE; SOD1 PROTEIN, MOUSE; SUPEROXIDE DISMUTASE; XANTHINE DERIVATIVE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; ELECTROPHYSIOLOGY; ENDPLATE POTENTIAL; FEMALE; HEMIDIAPHRAGM; MALE; MINIATURE ENDPLATE POTENTIAL; MOUSE; MUSCLE CONTRACTION; NEUROMODULATION; NEUROMUSCULAR SYNAPSE; NEUROMUSCULAR TRANSMISSION; NONHUMAN; ANALOGS AND DERIVATIVES; ANIMAL; DRUG EFFECTS; EVOKED RESPONSE; GENETICS; MOTOR END PLATE; NEUROMUSCULAR JUNCTION; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

ADENOSINE; ADENOSINE A1 RECEPTOR AGONISTS; ADENOSINE A2 RECEPTOR AGONISTS; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; EVOKED POTENTIALS; MICE; MOTOR ENDPLATE; NEUROMUSCULAR JUNCTION; PHENETHYLAMINES; RECEPTOR CROSS-TALK; RECEPTOR, ADENOSINE A1; RECEPTOR, ADENOSINE A2A; SUPEROXIDE DISMUTASE; SUPEROXIDE DISMUTASE-1; SYNAPTIC TRANSMISSION; XANTHINES;

EID: 84947612410     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-015-9465-4     Document Type: Article

References (33)

1. Swinnen B, Robberecht W (2014) The phenotypic variability of amyotrophic lateral sclerosis. Nat Rev Neurol 10(11):661–670. doi:10.1038/nrneurol.2014.184
2. Rosen DR (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 364(6435):362. doi:10.1038/364362c0
3. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX et al (1994) Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264(5166):1772–1775. doi:10.1126/science.8209258
4. Correia-de-Sá P, Sebastião AM, Ribeiro JA (1991) Inhibitory and excitatory effects of adenosine receptor agonists on evoked transmitter release from phrenic nerve ending of the rat. Br J Pharmacol 103(2):1614–1620. doi:10.1111/j.1476-5381.1991.tb09836.x
5. Rocha MC, Pousinha PA, Correia AM, Sebastião AM, Ribeiro JA (2013) Early changes of neuromuscular transmission in the SOD1(G93A) mice model of ALS start long before motor symptoms onset. PLoS One 8(9), e73846. doi:10.1371/journal.pone.0073846
6. Nascimento F, Pousinha PA, Correia AM, Gomes R, Sebastião AM, Ribeiro JA (2014) Adenosine A2A receptors activation facilitates neuromuscular transmission in the pre-symptomatic phase of the SOD1(G93A) ALS mice, but not in the symptomatic phase. PLoS One 9(8), e104081. doi:10.1371/journal.pone.0104081
7. Sebastião AM, Ribeiro JA (2009) Triggering neurotrophic factor actions through adenosine A2A receptor activation: implications for neuroprotection. Br J Pharmacol 158(1):15–22. doi:10.1111/j.1476-5381.2009.00157.x
8. Ferre S, Ciruela F, Quiroz C, Lujan R, Popoli P, Cunha RA, Agnati LF, Fuxe K, Woods AS, Lluis C, Franco R (2007) Adenosine receptor heteromers and their integrative role in striatal function. Sci World J 7:74–85. doi:10.1100/tsw.2007.211
9. Cunha RA, Johansson B, van der Ploeg I, Sebastião AM, Ribeiro JA, Fredholm BB (1994) Evidence for functionally important adenosine A2a receptors in the rat hippocampus. Brain Res 649(1–2):208–216. doi:10.1016/0006-8993(94)91066-9
10. Sheth S, Brito R, Mukherjea D, Rybak LP, Ramkumar V (2014) Adenosine receptors: expression, function and regulation. Int J Mol Sci 15(2):2024–2052. doi:10.3390/ijms15022024
11. Pousinha PA, Correia AM, Sebastião AM, Ribeiro JA (2010) Predominance of adenosine excitatory over inhibitory effects on transmission at the neuromuscular junction of infant rats. J Pharmacol Exp Ther 332(1):153–163. doi:10.1124/jpet.109.157255, jpet.109.157255 [pii]
12. Ribeiro JA, Sebastião AM (1987) On the role, inactivation and origin of endogenous adenosine at the frog neuromuscular junction. J Physiol 384:571–585. doi:10.1113/jphysiol.1987.sp016470
13. Ribeiro JA, Walker J (1975) The effects of adenosine triphosphate and adenosine diphosphate on transmission at the rat and frog neuromuscular junctions. Br J Pharmacol 54(2):213–218. doi:10.1111/j.1476-5381.1975.tb06931.x
14. Krebs HA, Henseleit K (1932) Untersuchungen uber die Harnstoffbildung im Tierkoper. Hoppe-Seyler’s Z Physiol Chem 210:33–37. doi:10.1515/bchm2.1930.192.1-3.25
15. Correia-de-Sá P, Timoteo MA, Ribeiro JA (1996) Presynaptic A1 inhibitory/A2A facilitatory adenosine receptor activation balance depends on motor nerve stimulation paradigm at the rat hemidiaphragm. J Neurophysiol 76(6):3910–3919
16. Lopes LV, Cunha RA, Ribeiro JA (1999) Cross talk between A(1) and A(2A) adenosine receptors in the hippocampus and cortex of young adult and old rats. J Neurophysiol 82(6):3196–3203
17. Pousinha PA, Correia AM, Sebastião AM, Ribeiro JA (2012) Neuromuscular transmission modulation by adenosine upon aging. Neurobiol Aging 33(12):2869–2880. doi:10.1016/j.neurobiolaging.2012.01.008, S0197-4580(12)00024-3 [pii]
18. Cristovao-Ferreira S, Navarro G, Brugarolas M, Perez-Capote K, Vaz SH, Fattorini G, Conti F, Lluis C, Ribeiro JA, McCormick PJ, Casado V, Franco R, Sebastião AM (2013) A1R-A2AR heteromers coupled to Gs and G i/0 proteins modulate GABA transport into astrocytes. Purinergic Signalling 9(3):433–449. doi:10.1007/s11302-013-9364-5
19. Ciruela F, Casado V, Rodrigues RJ, Lujan R, Burgueno J, Canals M, Borycz J, Rebola N, Goldberg SR, Mallol J, Cortes A, Canela EI, Lopez-Gimenez JF, Milligan G, Lluis C, Cunha RA, Ferre S, Franco R (2006) Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers. J Neurosci 26(7):2080–2087. doi:10.1523/JNEUROSCI.3574-05.2006
20. Lopes LV, Cunha RA, Kull B, Fredholm BB, Ribeiro JA (2002) Adenosine A(2A) receptor facilitation of hippocampal synaptic transmission is dependent on tonic A(1) receptor inhibition. Neuroscience 112(2):319–329. doi:10.1016/S0306-4522(02)00080-5
21. Palma AG, Muchnik S, Losavio AS (2011) Excitatory effect of the A2A adenosine receptor agonist CGS-21680 on spontaneous and K +-evoked acetylcholine release at the mouse neuromuscular junction. Neuroscience 172:164–176. doi:10.1016/j.neuroscience.2010.10.015
22. De Lorenzo S, Veggetti M, Muchnik S, Losavio A (2004) Presynaptic inhibition of spontaneous acetylcholine release induced by adenosine at the mouse neuromuscular junction. Br J Pharmacol 142(1):113–124. doi:10.1038/sj.bjp.0705656
23. Fuchs A, Kutterer S, Muhling T, Duda J, Schutz B, Liss B, Keller BU, Roeper J (2013) Selective mitochondrial Ca2+ uptake deficit in disease endstage vulnerable motoneurons of the SOD1G93A mouse model of amyotrophic lateral sclerosis. J Physiol 591(Pt 10):2723–2745. doi:10.1113/jphysiol.2012.247981
24. Ng SK, Higashimori H, Tolman M, Yang Y (2015) Suppression of adenosine 2a receptor (AR)-mediated adenosine signaling improves disease phenotypes in a mouse model of amyotrophic lateral sclerosis. Exp Neurol 267:115–122. doi:10.1016/j.expneurol.2015.03.004
25. Sebastião AM, Ribeiro JA (2009) Adenosine receptors and the central nervous system. Handb Exp Pharmacol 193:471–534. doi:10.1007/978-3-540-89615-9_16
26. Coughlan KS, Mitchem MR, Hogg MC, Prehn JH (2014) “Preconditioning” with latrepirdine, an adenosine 5′-monophosphate-activated protein kinase activator, delays amyotrophic lateral sclerosis progression in SOD1 mice. Neurobiol Aging. doi:10.1016/j.neurobiolaging.2014.09.022
27. Hawley SA, Davison M, Woods A, Davies SP, Beri RK, Carling D, Hardie DG (1996) Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J Biol Chem 271(44):27879–27887. doi:10.1074/jbc.271.44.27879
28. Ribeiro JA, Cunha RA, Correia-de-Sá P, Sebastião AM (1996) Purinergic regulation of acetylcholine release. Prog Brain Res 109:231–241. doi:10.1016/S0079-6123(08)62107-X
29. Vincenzi F, Corciulo C, Targa M, Casetta I, Gentile M, Granieri E, Borea PA, Popoli P, Varani K (2013) A2A adenosine receptors are up-regulated in lymphocytes from amyotrophic lateral sclerosis patients. Amyotrophic Lateral Sclerosis Frontotemporal Degeneration 14(5–6):406–413. doi:10.3109/21678421.2013.793358
30. Potenza RL, Armida M, Ferrante A, Pezzola A, Matteucci A, Puopolo M, Popoli P (2013) Effects of chronic caffeine intake in a mouse model of amyotrophic lateral sclerosis. J Neurosci Res 91(4):585–592. doi:10.1002/jnr.23185
31. Yanpallewar SU, Barrick CA, Buckley H, Becker J, Tessarollo L (2012) Deletion of the BDNF truncated receptor TrkB.T1 delays disease onset in a mouse model of amyotrophic lateral sclerosis. PLoS One 7(6), e39946. doi:10.1371/journal.pone.0039946
32. Correia-de-Sá P, Timoteo MA, Ribeiro JA (2000) A(2A) adenosine receptor facilitation of neuromuscular transmission: influence of stimulus paradigm on calcium mobilization. J Neurochem 74(6):2462–2469. doi:10.1046/j.1471-4159.2000.0742462.x
33. Tsentsevitsky A, Kovyazina I, Nikolsky E, Bukharaeva E, Giniatullin R (2013) Redox-sensitive synchronizing action of adenosine on transmitter release at the neuromuscular junction. Neuroscience 248:699–707. doi:10.1016/j.neuroscience.2013.05.065